Riya Gandhi, MA

QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies

09/15/2024

1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...

1. According to Dr Linda Stein...

09/15/2024

The Dermatologist

Quiz

QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis

08/10/2024

Riya Gandhi , MA;

What strategies did Dr Merola emphasize for atopic dermatitis?

What strategies did Dr Merola...

08/10/2024

The Dermatologist

Surgical Pearls

Dermatologic Surgery Pearls for Non-Mohs Surgeons

08/07/2024

Riya Gandhi , MA;

Consider words of wisdom from your colleagues and share what you have learned with others to help optimize patient care.

Consider words of wisdom from...

08/07/2024

The Dermatologist

NRS Approved Features

Establishing a Core Domain Set for Rosacea Clinical Trials

08/05/2024

Riya Gandhi , MA;

A recent consensus statement addresses the need for standardized outcome measures in clinical trials involving patients with rosacea.

A recent consensus statement...

08/05/2024

The Dermatologist

Clinical Insights

The Risk of Keratinocyte Cancer in Patients With Vitiligo

08/05/2024

Riya Gandhi , MA;

A recent systematic review and meta-analysis offers insights into the relationship between vitiligo and nonmelanoma skin cancer, which can be used to enhance patient education.

A recent systematic review and...

08/05/2024

The Dermatologist

FDA Alerts

Deuruxolitinib FDA Approved for Severe Alopecia Areata in Adults

07/30/2024

Riya Gandhi , MA;

The FDA has approved deuruxolitinib (LEQSELVI) 8 mg tablets for the treatment of adults with severe alopecia areata, a condition affecting approximately 300,000 individuals in the United States.

The FDA has approved...

07/30/2024

The Dermatologist

FDA Alerts

FDA Approves Roflumilast Cream 0.15% for Treatment of Atopic Dermatitis in Adults and Children Aged 6 and Older

07/09/2024

Riya Gandhi , MA;

The US Food and Drug Administration has approved roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis in adults and children aged 6 and older.

The US Food and Drug...

07/09/2024

The Dermatologist

News

Promising Patient Outcomes With Autologous Skin Cell Suspension Transplantation for Vitiligo

06/28/2024

Riya Gandhi , MA;

A new study highlights the effectiveness of autologous skin cell suspension transplantation in treating stable vitiligo, showing positive patient-reported outcomes and significant repigmentation improvements.

A new study highlights the...

06/28/2024

The Dermatologist

News

Evaluating Efficacy of Ritlecitinib With or Without nbUVB in Treating Non-Segmental Vitiligo

06/28/2024

Riya Gandhi , MA;

Ritlecitinib, a JAK3/TEC family kinase inhibitor, has shown promising results in the treatment of non-segmental vitiligo (NSV), according to a recent Phase 2b trial.

Ritlecitinib, a JAK3/TEC family...

06/28/2024

The Dermatologist